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Abstract. Neurofilaments (NFs), the major intermedi- 
ate filaments of central nervous system (CNS) and pe- 
ripheral nervous system (PNS) neurons, are hetero- 
polymers formed from the high (NFH), middle (NFM), 
and low (NFL) molecular weight NF subunits. To gain 
insights into how the expression of NF subunit proteins 
is regulated in vivo, two transgenes harboring coding 
sequences for human NFM (hNFM) with or without 
the hNFM multiphosphorylation  repeat domain were 
introduced into mice. Expression of both hNFM con- 
structs was driven by the hNFM promoter and resulted 
in increased levels of hNFM subunits concomitant with 
an elevation in the levels of mouse NFL (mNFL) pro- 
teins in the CNS of both lines of transgenic mice. The 
increased levels of mNFL appear specific to NFM be- 
cause previous studies of transgenic mice overexpress- 
ing either NFL or NFH did not result in increased ex- 
pression of either of the other two NF subunits. 
Further, levels of the most heavily phosphorylated iso- 
forms of mouse NFH (mNFH) were reduced in the 
brains of these transgenic mice, and electron micro- 
scopic studies showed a higher packing density of NFs 
in large-diameter CNS axons of transgenic versus wild- 
type mice. Thus, reduced phosphorylation of the 
mNFH carboxy terminal domain may be a compensa- 
tory response of CNS neurons to the increase in NFs, 
and reduced negative charges on mNFH sidearms may 
allow axons to accommodate more NFs by increasing 
their packing density. Taken together, these studies im- 
ply that NFM may play a dominant role in the in vivo 
regulation of the levels of NFL protein, the stoichiome- 
try of NF subunits, and the phosphorylation state of 
NFH. NFM and NFH proteins may assume similar 
functions in regulation of NF packing density in vivo. 
M  AMr~IALtaN  neurofilaments (NFs) 1  belong to a large 
family of intermediate filaments (IFs)  that are 
found in nearly all mammalian cells, and NFs 
are the major IFs of central nervous system (CNS) and pe- 
ripheral  nervous  system  (PNS)  neurons  (Hoffman and 
Lasek, 1975; Liem et al., 1978; Schlaepfer and Freeman, 
1978). NFs share many structural and biochemical features 
common to  IFs  formed from each  of the  six  different 
classes (i.e., types I-VI) of IF proteins, but NFs possess 
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several  unique  characteristics  (for  recent  reviews  see 
Nixon, 1993; Fuchs and Weber, 1994). For example, unlike 
homopolymeric IFs that are composed of type III IF pro- 
teins (e.g., vimentin, peripherin) or the heteropolymeric 
IFs  formed from type  I  and  II  keratins,  NFs  are  het- 
eropolymers of three distinct subunit proteins. Because of 
the unique structure of their genes, the NF triplet proteins 
are included in a separate class (i.e., type IV) of IF pro- 
teins,  and  they are  known as  the  high  (NFH),  middle 
(NFM),  and low  (NFL)  molecular weight  NF subunits. 
Further, both NFM and NFH have extraordinarily long 
carboxy terminal domains, and their apparent molecular 
weights  (Mr)  as  determined  by  SDS-PAGE  are  much 
higher than that deduced from their corresponding amino 
acid or cDNA sequences.  This is thought due to the com- 
bined effects of a high content of negatively charged Glu 
residues and repeated motifs containing Lys, Ser, and Pro 
(KSP motifs) that are referred to as multiphosphorylation 
repeats (MPR) and are the major sites of phosphorylation 
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stoichiometry of NFs  varies  among  different  CNS  and 
PNS regions, and differs from the stereotyped 1:1 ratio of 
type I and II IF proteins seen in heteropolymeric keratin 
IFs (reviewed in Fuchs and Weber,  1994). For example, 
more NFH seems required in regions where the axonal di- 
ameters are large (e.g., spinal cord and sciatic nerve), com- 
pared with regions that primarily contain thin axons (e.g., 
neocortex). Although NFL is  able  to self-assemble into 
long, 10-nanometers-in-diameter filaments in vitro (Gei- 
sler and Weber, 1981; Liem and Hutchison, 1982; Mulligan 
et al., 1991; Balin and Lee, 1991), recent data suggest that 
NFL is not competent to form a filamentous network in 
vivo (Ching and Liem, 1993; Lee et al.,  1993).  In contrast 
to NFL, both NFM and NFH appear to subserve an auxil- 
iary function, and current structural models of NFs, sug- 
gest that NFL alone forms the core of individual NFs while 
NFH  and  NFM  are  bound  to  the  surface  of these  NFs 
(Liem and Hutchison, 1982; Nixon, 1993). 
Despite the rapid  accumulation  of biochemical, struc- 
tural,  genetic, and pathological information on NFs and 
their subunit proteins, the precise function(s) of NFs still 
remains only partially understood (Nixon, 1993). For ex- 
ample, NFs have been considered major determinants of 
the caliber of large-diameter axons (Hoffman et al., 1984, 
1987), and it is the caliber of axon that controls the con- 
duction velocity of action potentials in large, heavily my- 
elinated  axons  (Sakaguchi  et  al.,  1993).  NFs  also  are 
thought to provide mechanical support for axons and to 
form a stable structural matrix within axons during neurite 
outgrowth and elongation to facilitate axonal pathfinding 
in the developing nervous system (Landmesser and Swain, 
1992). However, recent studies of an NF-deficient mutant 
quail has again raised questions about the functional im- 
portance of NFs in vivo (Yamasaki et al., 1992; Ohara et 
al., 1993). 
To elucidate the structure and function of NFs as well as 
other aspects of the biology of NFs in vivo, a number of 
different transgenic mice have been developed and used as 
experimental model systems. For example, transgenic mice 
have been used to identify promoter sequences that direct 
tissue-  or  cell-type  specific  expression  of  NF  proteins 
(Julien et al., 1987; Lee et al., 1992; Reeben et al., 1993; El- 
der et al., 1994), to probe the alternative adenylation of 
NFL mRNA (Beaudet et al., 1993a), to dissect out the reg- 
ulatory sequences that control the levels of NF proteins 
(Beaudet et al., 1992), and to establish animal models of 
human neurodegenerative diseases (C6t6 et al., 1993; Xu 
et al., 1993; Eyer and Peterson, 1994; Vickers et al., 1994). 
To gain insights into the role NFM might play in regulat- 
ing  the  level  of endogenous  mouse  NFL  (mNFL)  and 
NFH (mNFH), two different lines of transgenic mice that 
constitutively overexpress human NFM (hNFM) were ex- 
amined in this study. In contrast to earlier transgenic mice 
designed to overexpress NFL or NFH, the overexpression 
of hNFM in both lines of transgenic mice described here 
induced  increased  levels  of mNFL proteins  and  dimin- 
ished the levels of the most heavily phosphorylated iso- 
forms of mNFH. Based on our studies of these transgenic 
mice, we conclude that NFM may play a dominant role in 
regulating  NFL  level  and  the  phosphorylation  state  of 
NFH in vivo. 
Materials and Methods 
Transgenic Mice 
The two new lines of hNFM transgenic mice studied here were generated 
as described earlier (Lee et al., 1992; Elder et al., 1994).  The transgenic 
mice were identified by Southern blot analysis of tail DNA as described 
(Lee et al., 1992; Cole et al., 1994; Elder et al., 1994). The transgene copy 
number in each line was also determined by Southern blot analysis of tail 
DNA digested with BamHI and probed with pNF4 (Myers et al., 1987), 
which hybridized with both endogenous and transgenic NFM DNAs. The 
copy number of the transgenes was estimated by determining the ratio of 
the transgenic hNFM DNA to the endogenous mNFM DNA. 
Quantitative Western Blots 
Transgenic and age-matched wild-type mice were sacrificed by carbon di- 
oxide asphyxiation. Different regions of the CNS were dissected out im- 
mediately and homogenized in BUST buffer (8 M  urea, 0.5%  SDS, 2% 
13-mercaptoethanol, and 50 mM Tris, pH 7.4) at a ratio of i  ml/100 mg wet 
tissue, according to previously described methods (Lee et al., 1992; Cole et 
al., 1994). The tissue suspensions were sonicated well and centrifuged in a 
TL-100 ultracentrifuge (Beckman Instruments, Fullerton, CA) at 100,000 g 
for i  h  at 25°C, and the protein concentrations in the supernatants were 
determined. Proteins were separated on 7.5% SDS-PAGE gels, arid dif- 
ferent amounts of total protein from different tissues were loaded in each 
lane of a gel according to the following scheme: neocortex and hippocam- 
pus, 40 Ixg; brain stem, 20 ~g; and spinal cord and peripheral nerves, 10 
p.g.  For  quantitative  experiments, identical  amounts of proteins  from 
transgenic and control samples were loaded in groups of six separate lanes 
of the same gel. Gels were transferred to nitrocellulose membranes for 
qualitative and quantitative Western blot studies as described (Balin et al., 
1991; de Waegh et al., 1992; Lee et al., 1992; Bramblett et al., 1993; Cole et 
al., 1994). The membranes were blocked for 1 h in TBS, pH 7.6, containing 
5% nonfat milk. Primary antibodies specific for each of the NF subunits, 
some of which recognize NFH or NFM in different states of phosphoryla- 
tion (see Table  I), were applied to the nitrocellulose membranes over- 
night. After five washes in GB buffer (50 mM triethanolamine, 100 mM 
NaCl, 2 mM EDTA, 1 mM sodium azide, 0.1%  SDS, and 0.5%  Triton 
X-100, pH 7.5) and a final wash in PTX buffer (10 mM phosphate buffer, 
pH 7.3, 300 mM NaC1,  2  mM EGTA, 2  mM sodium azide), the mem- 
branes were probed with either 10 txCi I125-1abeled goat anti-mouse IgG 
(ICN Radiochemicals, Irviue, CA) for mouse primary antibodies or  10 
~Ci I125-1abeled Protein A  (ICN) for rabbit primary antibodies for 1 h. 
After 5 washes in GB buffer, the blots were dried and placed on Phosphor- 
Imager plates (Molecular Dynamics, Sunnyvale, CA) for 4 h. The plates 
were then scanned, and the abundance of bound antibody overlying the 
labeled bands was quantified with ImageQuant software (Molecular Dy- 
namics). 
Table L Result of lmmunohistochemistry Staining 
NFMBam- versus Wild Type 
Staining 
Antibody  Dilution  Epitope  intensity 
RMO3  Neat  NFM, Pind/tail outside MPR  + + 
RMO44  100 ×  NFM, Pind/core  + + 
RMO189  100 x  NFM, Pind/core  + 
RMO254  500 x  NFM, Pind/tail within MPR  = 
RMO255  200 x  NFM, Pind/tail the last 20 aa  + + 
Rabbit Anti-NFL  2000 x  NFL, Pind/tail  + + 
RMO24  10 x  NFH, P 3+/tail within MPR  +/- 
RMDO9  1000 x  NFH, P-/tail without MPR  +/= 
RMO217  10 ×  NFH, P2+/tail within MPR  +/= 
Three pairs of 3-mo-old and two pairs of 1-mo-old mice were compared. Neocor- 
tex and alveus of hippocampus were used for comparison, pS+, heavily phospho- 
rylated epitope in NFH; pZ+, moderately phosphorylated epitope in NFH; P-, 
non- or poorly phosphorylated epitope in NFH; Pind, phosphorylation-indepen- 
dent epitope in NFM or NFL; MPR, multiphosphorylation repeats in human 
NFM or mouse NFH; (+), slightly stronger staining intensity in NFMBam- mice 
than  in  wild-type  mice;  (++),  prominently  stronger  staining  intensity  in 
NFMBam-  mice  than  in  wild-type  mice;  =,  equal  staining  intensity  in 
NFMBam- and wild-type mice; +/- and +/=, variable staining intensity results. 
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Isolation of total cellular RNA from whole-brain and RNase protection 
assays was performed on 1-mo-old to 3-mo-old trangenic mice and their 
corresponding wild-type  age-matched controls, as previously described 
(Lee et al.,  1992), with  [a_32p] UTP-labeled probes. The murine NFM 
and murine [~-actin  probes have been described previously (Lee et al., 
1992).  To construct a probe for murine NFL, a cDNA clone containing 
amino acid 22 to the poly A  site cloned as a SmaIfEcoRI in pUC8 (gift of 
Dr. N. Cowan), was cloned as a SalI/EcoRI fragment into pBluescript II 
SK+. NFL sequence 3'  to  the Sacl site at amino acid 415  (Lewis and 
Cowan,  1986)  was  removed  by digesting with  SacI  and religating  the 
ends. For use as a probe template, this final plasmid was digested at a 
KpnI site found at amino acid 368, made blunt ended with T4 DNA poly- 
merase, and  a  probe  was synthesized with T3  RNA polymerase. This 
probe protected a 140-bp product. A murine glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH)  cDNA in pBSIIKS  (pCCD32)  was obtained 
from Dr. D. Werner (Lu et al., 1990). After digestion with AvaII, a T7 
RNA polymerase-generated probe protected a 240-bp fragment. 
Each reaction contained 5-p.g brain RNA and 5-1~g tRNA. Quantita- 
tion was done by densitometry. To ensure linearity, a  set of RNA stan- 
dards containing 0-10 ~g wild-type brain RNA supplemented with tRNA 
as needed to give 10 I~g in each sample was run in all experiments. Exper- 
imental samples were always run in duplicate. Murine NFL and NFM lev- 
els were normalized to the levels of actin or GAPDH expression, respec- 
tively. 
Immunohistochemistry 
The properties of the anti-NF-subunit-specific antibodies used here are 
summarized in Table I. Tissue fixation by immersion in 70% ethanol/150 
mM NaCI, as well as tissue processing and sectioning and the immunohis- 
tochemical procedures used here are described in a  number of publica- 
tions (e.g., Lee et al., 1986, 1987; Trojanowski et al., 1986, 1989; Carden et 
al.,  1987;  Schmidt et al.,  1987,  1991).  Briefly, the immunohistochemical 
procedures involved application of the primary anti-NF protein antibody 
overnight at 4°C, followed by the detection of bound antibody using a per- 
oxidase  anti-peroxidase  or  avidin  biotin  complex reporter  system. To 
demonstrate quantitative differences in the immunohistochemical-stain- 
ing intensity obtained with some of these antibodies, 6-~m-thick sections 
from the same brain levels of transgenic as well as control mice were cut 
and placed side by side on the same slides for comparative immunohis- 
tochemical studies with the same antibody. 
Electron Microscopic Studies 
Adult transgenic and age-matched control mice were sacrificed by carbon 
dioxide asphyxiation and perfusion-fLxed through the heart, as described 
earlier (Trojanowski and Gonatas, 1983; Cole et al., 1994).  After flushing 
the intravascular compartment with 50 ml of 0.1 M  cacodylate buffer pH 
7.4, the mice were perfused with 50 ml of fixative (2% paraformaldehyde 
and 2% glutaraldehyde/0.1 M cacodylate buffer, pH 7.4). The brains were 
dissected out and immersion-fixed for an additional 24 h. Samples, includ- 
ing the  alveus and  adjacent  hippocampus, from  one  of the  transgenic 
mouse lines (i.e., the NFMBam- mice described in Results) and from the 
wild-type mice were trimmed to I mm  3 under a dissecting microscope; the 
samples were postfixed in osmium tetroxide for 20 min, dehydrated, and 
then embedded in Epon-Araldite resin. For morphometric studies of the 
density of NFs in axons running in the alveus, ultrathin sections through the 
alveus and adjacent hippocampus were examined under an electron micro- 
scope (Hitachi, H-600, Nissei Sangyo, America Ltd., Gaithersburg, MD). 
60 axons from the alveus of each animal were photographed at a nominal 
magnification of x20,000. Axons in the white matter of the alveus cut ex- 
actly in cross-section were randomly selected, and all of the NFs in each of 
these axons were counted using methods similar to those described earlier 
(Cole et al., 1994).  For quantitation, we arbitrarily classified these axons 
into the following six size categories: axons with diameters 0.1-0.3, 0.3-0.5, 
0.5-0.7, 0.7-0.9, 0.9-1.2, and 1.2-1.5 p,m. We then counted the number of 
NFs per axon and, for both transgenic and wild-type mice, grouped these 
data together for axons belonging to each of the size categories. 
Statistical Analyses 
Statistical analyses of the quantitative immunoblot data and of the mor- 
phometric data on the density of NFs were performed using a t test and 
Microsoft Excel software as described (Cole et al., 1994). 
Results 
Production of Transgenic Mice 
Three lines of transgenic mice  carrying hNFM transgene 
were  generated.  The  NFM27  line was  characterized  and 
reported earlier (Lee et al., 1992), and studies of this line 
are not presented  here  except  to compare  the transgene 
copy number in the NFM27 mice with the other two lines 
of transgenic mice, because our previous study (Lee et al., 
1992)  showed low levels  of hNFM  protein expression in 
this line (Fig. 1). The second line (designated NFM37) car- 
ried a transgene containing full-length genomic DNA en- 
coding hNFM with 2.8 kb of upstream sequences (Elder et 
al., 1994). The third line (designated NFMBam-)  carried 
a  transgene  that  harbored  a  truncated  version  of  the 
hNFM gene devoid of a 726-bp-long BamHI-BamHI frag- 
ment  of  DNA  containing  the  coding  sequence  for  the 
hNFM MPR domain in the third exon of the hNFM gene 
(Myers et al., 1987). Both transgenes were transmitted in a 
Mendelian fashion. The NFMBam-  line was bred to ho- 
mozygosity,  but  the  NFM37  line  remained  hemizygous. 
The NFM27 line was estimated to have ~6 copies of trans- 
gene,  the  homozygous  NFMBam-,  12  copies,  and  the 
hemizygous  NFM37  ~12  copies.  None  of  the  3-mo-old 
hemizygous NFM37, homozygous NFMBam-,  or 1-yr-old 
homozygous  NFMBam-  transgenic  mice  showed  evi- 
dence  of  intraneuronal  NF  inclusions,  even  though  the 
1-yr-old NFM27  mice  develop  neurofibrillary  accumula- 
tions in their cortical neurons (Vickers et al., 1994). 
Distribution of hNFM mRNA in the CNS of 
Transgenic Mice 
Northern blot analysis of different CNS regions was per- 
formed to  determine  the  expression levels of the  trans- 
genic hNFMBam-  mRNA in the NFMBam-  mice. The 
expression of the full-length hNFM transgene driven by its 
own  promoter  was  previously  shown  to  be  restricted 
mainly to neural tissues (Lee et al.,  1992).  Since less NF 
mRNA transcripts were present in the hippocampus and 
neocortex than in brain stem and spinal cord, 50 p~g of to- 
tal RNA from hippocampus and neocortex and 20 p~g of 
total RNA from brain stem and spinal cord were loaded in 
each  lane.  The  pNF4  probe  detected  an  mRNA  band 
Figure  1.  Transgene  copy  numbers  in  three  hNFM  transgenic 
lines  by  Southern  blot  analyses.  15-p~g tail  DNA  from  mice  of 
each of the three human NFM transgenic lines were digested with 
BamHI,  fractionated,  and  hybridized  with  [ct-a2p]dCTP-labeled 
pNF4 (NFM) probe to document the copy numbers of the trans- 
genes. The estimated copy number was obtained by doubling the 
ratio  of transgenic hNFM  to  endogenous mNFM  (listed  above 
the Southern blot).  C1  and C2 represent BALB-c  and C57BI/6J 
×  DBA2J  hybrid mice, respectively. 
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of  NFMBam-  mice  (Fig.  2  A).  The  same  blots  were 
stripped  and  reprobed  with  the  BamHI-BamHI DNA 
fragment that is deleted in the NFMBam- transgene, and 
only the  endogenous  mNFM mRNA  was seen  in  trans- 
genic mice  (data  not  shown),  which  confirmed that  this 
shorter band was the transgenic hNFMBam- mRNA. 
The  ratio  of hNFMBam-  mRNA  to  mNFM  mRNA 
was calculated as described earlier. Quantitative Northern 
blot  analyses  demonstrated  that  the  relative  expression 
levels of transgenic mRNA varied among different regions 
of the  CNS  (Fig.  2  B).  Hippocampus and  neocortex ex- 
pressed as much hNFM mRNA as mNFM mRNA. How- 
ever, in brain  stem and  spinal cord,  the  transgene  tran- 
scripts were about half of the endogenous mNFM mRNA. 
If the amount of RNA loaded for each region is taken into 
consideration, the absolute amounts of hNFMBam- mRNA 
transcripts in the brain stem and spinal cord are equal to 
or greater than those in neocortex and hippocampus. The 
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Figure 2.  The relative expression  levels of hNFM mRNA in dif- 
ferent regions  of the nervous system of 3-mo-old  NFMBam- 
transgenic  mice. (A) Northern blots of four different regions  of 
the nervous system were generated with the pNF4 (NFM) cDNA 
probe, which recognized  both hNFMBam- and mNFM mRNA 
bands. The amount of total RNA in each lane is as follows: neo- 
cortex, 50 ~g; hippocampus,  50 I~g;  brain stem, 20 ~g; spinal cord, 
20 ~g. (B) Bar graphs of the ratios of the hNFMBam- to mNFM 
mRNA signals. Each bar represents at least six observations ob- 
tained from quantitative Northern blots of 12 age-matched ani- 
mals. In one blot, each sample was identically loaded into three 
lanes of a given blot, and the amount of radioactivity  in the three 
lanes from the same sample was averaged and considered as 
one  observation.  The  neocortex  and  hippocampus  expressed 
hNFMBam- mRNA at higher relative levels than the brain stem 
and spinal cord. BS, brain stem; HIP, hippocampus;  NEO, neo- 
cortex; SC, spinal cord; TG, transgenic; WT, wild type. 
the hNFM mRNA was expressed at relatively high levels 
both in brain and spinal cord (Elder et al., 1994). 
Transgenic hNFM Protein Expression  Correlates 
with hNFM mRNA Levels 
Well-characterized  monoclonal  (mAbs)  and  polyclonal 
antibodies  (Table  I)  specific for NF  proteins  (including 
mAbs that  distinguish  between differentially phosphory- 
lated isoforms of NFH and NFM) were used for immuno- 
blot studies of transgenic and wild-type mice. Quantitative 
Western  blots  revealed  an  hNFMBam-  band  in  the 
NFMBam- mice of ~100 kD, whereas the Mr of hNFM in 
the NFM37 line was ~170 kD (Fig. 3, A  and C). The large 
molecular weight difference resulted not only from the de- 
letion of 242 amino acids in hNFMBam- protein, but also 
from the inability of the NFMBam- to be phosphorylated 
because  the  major  phosphorylation  sites  are  contained 
within  the  deleted  region.  The  full-length  transgenic 
hNFM protein had the same Mr as that of native, heavily 
phosphorylated hNFM protein, and it was recognized by 
mAb HO14, which binds specifically to heavily phospho- 
rylated hNFM protein (data not shown, but see Lee et al., 
1992;  Schmidt  et  al.,  1987).  These data  suggest  that  this 
full-length transgenic hNFM protein was phosphorylated 
in murine neurons to the same extent as in human neurons 
of the normal adult CNS. 
The ratio of hNFM and hNFMBam- protein to endoge- 
nous  mNFM  protein  was  used  to  estimate  the  relative 
abundance of the transgenic protein in the CNS. Neocor- 
tex  and  hippocampus  expressed  as  much  hNFMBam- 
protein as mNFM, but the brain stem and spinal cord ex- 
pressed much lower levels of hNFMBam- protein, that is, 
~35%  of those for mNFM protein (Fig. 3 B). Peripheral 
nerves such as the sciatic and trigeminal nerves also con- 
tained  relatively lower levels of transgenic  hNFMBam- 
protein (data not shown).  However, when the amount of 
protein loaded was taken into consideration, the absolute 
amount of hNFMBam-  protein in brain stem and spinal 
cord of the NFMBam- mice was very similar to that seen 
in the neocortex and hippocampus of these same mice. 
The levels of the transgenic hNFMBam- protein in the 
four  nervous  regions  correlated  with  their  hNFMBam- 
mRNA levels. The high levels of hNFM protein observed 
in  all CNS regions tested  in line  NFM37  (Fig.  3 D)  also 
correlated with a relatively high level of hNFM RNA ex- 
pression in this line (Elder et al., 1994).  We have also ob- 
served a  close relationship between human NFM mRNA 
and its protein levels in a previously described transgenic 
line NFM27 (Lee et al., 1992).  Thus, it seems likely that in 
all these lines, the level of hNFM protein is controlled pri- 
marily at the transcriptional level. 
Transgenic hNFMBam- Proteins Are Incorporated 
into Intermediate  Filaments In Vivo 
To  monitor  the  copolymerization  of  hNFMBam-  with 
other  endogenous  mouse  NF  subunits  into  IFs  in  vivo, 
neocortical samples of the  NFMBam-  and  control mice 
were  extracted  with  a  high-salt  buffer containing  Triton 
X-100. This buffer separates unincorporated proteins into 
the supernatant while retaining the proteins assembled as 
IFs in the pellets (Fig. 4 A). Quantitative Western blotting 
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Figure 3.  The relative expression  levels of the transgenic  NFM 
protein in different regions of the nervous system. A and C repre- 
sent quantitative Western blots of different CNS regions from the 
NFMBam- and NFM37 transgenic mice, respectively. The blots 
were  probed  with  RMO189  (a  phosphorylation-independent 
NFM mAb), which recognizes both the endogenous mNFM and 
transgenic  hNFMBam-  and hNFM protein. B  and D  are bar 
graphs showing the relative expression levels of hNFMBam- and 
hNFM to endogenous mNFM protein in different CNS regions, 
respectively. Each bar represents at least six observations ob- 
tained  from quantitative Western  blots of three pairs of sex- 
matched 3-mo-old  adult  mice.  Note that in  NFMBam-  mice, 
neocortex  and  hippocampus  regions  express  higher  levels  of 
hNFMBam- protein than brain stem and spinal  cord regions, 
and in NFM37 mice, all four CNS regions express high levels of 
hNFM transgenic mice. (For definitions, see Fig. 2.) 
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Figure4. Incorporation ofhNFMBam- protein into NFsin vivo. 
(A) A representative quantitative Western blot of neocortex ex- 
tracted with Triton X-l(Kl--containing buffer.  Triplicate  samples 
of 40-~g total protein from each pellet (P) and supernatant (S) of 
neocortical  tissue  from  transgenic  NFMBam-  and  wild-type 
mice were loaded. The blots were overexposed to show the faint 
NF bands in supernatants.  B-D show quantitative bar graphs of 
soluble portions of NFM, NFH, and NFL proteins in transgenic 
and wild-type mice. Each bar represents six observations as in A 
of three pairs of 3-mo-old animals. There is no significant differ- 
ence between the soluble  portion of hNFMBam-  protein and 
that of mNFM protein in transgenic or wild-type mice. The solu- 
ble portions of NFH and NFL proteins in transgenic mice are also 
similar to those in wild-type mice. (For definitions, see Fig. 2.) 
showed  that  ~90%  of  hNFMBam-  transgenic  protein 
was retained in the pellets and only 10% was recovered 
in  the  soluble  fraction.  This  percentage  of  soluble 
hNFMBam-  protein  was  very  close  to  that  of  soluble 
mNFM protein in both the transgenic and wild-type mice 
(Fig. 4 B). These results demonstrated that hNFMBam- 
transgenic  proteins  were  incorporated  into  filaments  in 
vivo to  the  same extent  as  the  endogenous  mNFM pro- 
teins, regardless of the deleted MPR in the tail domain of 
the transgenic NFM protein. Furthermore, the transgenic 
protein  did  not  appear to  displace  endogenous  NF  pro- 
teins  from NFs  since  the  percentage  of soluble  mNFM, 
mNFL, and mNFH in the NFMBam- mice was similar to 
that in the wild-type mice (Fig. 4, C and D). 
The Expression of hNFM in Transgenic Mice Is 
Associated with Increased Accumulation of mNFL 
Because NFs are obligate heteropolymers of the NF trip- 
let, and these subunits are assembled into NFs with a  de- 
fined  stoichiometry in  vivo, we  sought  to  determine  the 
consequences  of the  expression of the hNFM protein on 
the relative levels of the endogenous mouse NF subunits 
in the transgenic mice. Representative immunoblots of the 
NF  proteins  from  NFMBam-  and  NFM37  transgenic 
mice versus wild-type mice that were used for quantitation 
are  shown  in  Fig.  5.  Remarkably,  quantitative  data  of 
these blots demonstrated that mNFL protein increased in 
the CNS of both lines of transgenic mice relative to those 
of wild-type mice. In NFMBam- mice, there was a consis- 
tent twofold increase in the relative abundance of mNFL 
in the neocortex and hippocampus, where the relative lev- 
els of transgenic hNFMBam- proteins were high (Figs. 5 
A, and 6, A  and C). In contrast, in the spinal cord, where 
the  level  of  hNFMBam-  proteins  was  only  ~35%  of 
mNFM proteins, the relative abundance of mNFL of these 
mice was similar to that of the wild-type mice (Fig. 5 B). 
However, mNFL was also increased in  the  brainstem of 
the  NFMBam-  mice (i.e., similar to neocortex and hip- 
pocampus), despite the fact that the hNFMBam- proteins 
were  expressed  at  a  level  of  only  40%  of  that  of  the 
mNFM protein. Similar studies of the NFM37 transgenic 
mice revealed a similar increase of mNFL protein in all of 
the  CNS regions where the relative levels of hNFM pro- 
teins were high (Figs. 5, C and D, and 6, D  and F). 
Increased mNFL in Transgenic Mice Is Regulated 
at the Posttranscriptional Levels 
To determine  if the  increase  in  mNFL protein  in  trans- 
genie mice resulted  from an  increase  in  mNFL message 
levels, RNase protection assays were conducted  on both 
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mice versus wild-type  mice and NFM37 versus wild-type  litter- 
mate mice  that were used for quantitation.  Six identical  lanes 
from either neocortex or spinal cord of transgenic and wild- 
type mice were loaded in one gel and transferred to nitrocellu- 
lose membranes. The blots of NFMBam- versus wild-type mice 
were cut into three parts. The NFH bands were revealed with the 
mAb RMO24, which recognized  murine heavily phosphorylated 
NFH (mNFH p3+) epitope; the  NFM bands  were revealed 
with the mAb RMO189,  which recognized  the rod domains of 
hNFMBam- and mNFM proteins, and the NFL bands were re- 
vealed with a polyclonal rabbit anti-NFL antiserum. The blots of 
NFM37 versus wild-type mice were cut into two parts.  The top 
part was incubated with the antibody mixture of either RMO24 
and RMO189  (C) or RMdO9 and RMO189  to reveal the non- 
phosphorylated NFH isoform (mNFH P-) (D) in neocortex of 
NFM37 mice. The bottom part was incubated with the polyclonal 
rabbit anti-NFL antiserum. 
NFMBam-  and NFM37  transgenic mice using a  murine 
NFL  probe  that  protected  a  140-bp  segment  of  mNFL 
mRNA (Fig. 7 A). These studies showed that the levels of 
mNFL mRNA in both lines of transgenic mice were not el- 
evated compared with age-matched wild-type mice (Table 
II). These data suggest that the induction of mNFL protein 
in the transgenic mice is regulated by posttranscriptional 
mechanisms. Further, RNase protection assays of mNFM 
(Fig. 7 B) showed that the levels of mNFM mRNA in both 
lines  of transgenic  mice also  remained  unchanged  when 
compared with the control mice (Table II), and this was 
consistent with the finding that the levels of mNFM pro- 
tein in the transgenic mice were the same as those in the 
control mice (Figs. 5 and 6). 
mNFH Subunits Are Phosphorylated to a Lesser Extent 
in Transgenic Mice Than in Wild-Type Mice 
In view of the shared structural  and biochemical proper- 
ties of mNFH and hNFM that may render similar domains 
in these NF proteins (e.g., the MPR domains) functionally 
redundant,  we sought to determine if the overexpression 
of hNFM might influence posttranslational modifications 
(e.g., phosphorylation) of mNFH that are thought to regu- 
late the dynamic functions of these proteins (de Waegh et 
al., 1992; Nixon, 1993; Cole et al., 1994). Using the RMO24 
mAb  (which  recognizes  a  heavily  phosphorylated  or 
mNFHP  3+  epitope)  and  the  mAb  RMdO9  (which  rec- 
ognizes  a  nonphosphorylated  or mNFHP-  epitope), we 
noted that the neocortex, hippocampus, and brainstem of 
the NFMBam-  mice had 20%  less mNFH p3+  isoforms 
than the same regions in the wild-type mice (Fig. 6, A  and 
B).  A  similar  decrease  in  the  abundance  of the  highly 
phosphorylated mNFH p3+ was also observed in the brains 
of the NF37 transgenic line (Figs. 5, C and D, and 6, D  and 
E). Furthermore, a protein band with a molecular weight 
similar to that of the  mNFHP-  isoform was detected in 
the  neocortex  (Fig.  5  D)  and  hippocampus  (data  not 
shown) of NFM37 mice by RMdO9 mixed with RMO189, 
but not by RMO24 mixed with RMO189 (Fig. 5 C). Since 
the same band also was detected by RMdO9 alone (data 
not shown), this band undoubtedly was the poorly phos- 
phorylated  mNFHP-  protein.  Interestingly, we  did  not 
see this band in the same brain regions of the NFMBam- 
mice (data not shown). There was no significant diminu- 
tion  in  the  levels of the  highly  phosphorylated NFHP  3+ 
isoforms in the spinal cord of either the NFMBam-  (Fig. 
6, A  and B) or the NFM37 mice (Fig. 6, D  and E). Thus, 
our data suggest that the phosphorylation state of mNFH 
protein  decreased  in  the  telencephalic  neurons  of both 
transgenic lines, and that this occurred to a greater extent 
in the NFM37 mice than in the NFMBam- mice. 
Antibodies to NF Subunits Differentially Stain 
Axons of Transgenic versus Wild-Type Mice 
Immunohistochemistry was used to confirm the Western 
blot data and to visualize the differential expression of NF 
proteins  in  the  1.5-  and  3-mo-old transgenic  versus  the 
wild-type mice in situ. We focused our observations on the 
neocortex  and  hippocampus  because  these  two  regions 
had the highest relative levels of the transgenic hNFM pro- 
tein. Fig. 8 shows representative data from the NFMBam- 
mice, which were obtained with three different antibodies 
to NF subunits, and Table I summarizes the results of the 
immunohistochemical  studies  conducted  with  all  of  the 
anti-NF protein antibodies in this line of transgenic mice. 
There was no  obvious difference in  the  staining inten- 
sity  of  axons  produced  with  the  mAb  RMO254  in  the 
NFMBam-  versus  the  wild-type  mice,  and  this  mAb 
(which recognizes the NFM MPR epitope deleted in the 
transgenic hNFMBam- protein) was used as a control an- 
tibody (compare Fig.  8, A  and D).  However, other anti- 
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Figure 6.  The induction of the mNFL 
protein  and  a  reduction  of  the 
mNFHP  3+  isoform  in  transgenic 
mice.  A  and D  are Western blots of 
four  CNS  regions  from  3-mo-old 
NFMBam-  versus  wild-type,  and 
NFM37  versus  wild-type  mice,  re- 
spectively.  The  blots  were  cut  into 
three  parts  each,  which  were  incu- 
bated  with  RMO24  (mNFHP3+), 
RMO189  (NFM),  and  rabbit  anti- 
NFL  polyclonal  antiserum,  respec- 
tively. B and C are quantitative ratios 
of  the  mNFHP  3+  isoform  and  the 
mNFL  protein  of  NFMBam-  to 
wild-type mice, E and F show similar 
ratios  of NFM37  to wild-type mice. 
Each bar represents the average of at 
least  6  separate  observations  from 
quantitative  Western blots shown in 
Fig. 5 of three pairs of animals.  One 
observation was defined as the aver- 
age of the radioactivity counts of the 
six identical lanes from one sample in 
one gel. Note that there is a 20% re- 
duction in the mNFHP  3+ isoform and 
a twofold increase in mNFL protein 
in  the  regions  overexpressing  high 
relative levels of hNFM protein both 
in NFMBam-  (e.g., NEO, HIP, and 
BS)  and  NFM37  (e.g.,  NEO,  HIP, 
and BS). Interestingly, there is no sig- 
nificant reduction  in  the  mNFHP  3+ 
isoform  in  the  spinal  cord  of  the 
NFM37 mice, even though there is a 
moderate induction of NFL protein. 
NFM  antibodies  (e.g.,  RMO44)  to  epitopes  that  were 
shared between transgenic and endogenous NFM proteins 
stained  axons  in  the  hippocampus  and  neocortex  of the 
NFMBam-  mice  more  strongly  than  did  the  wild-type 
counterparts (compare Fig. 8, B  and E). Further, the stain- 
ing intensity of axons in the NFMBam-  mice with a rabbit 
anti-NFL polyclonal antiserum also was stronger than that 
seen  in  the  wild-type  mice  (compare  Fig.  8,  C  and  F). 
However,  the  three  anti-NFH  antibodies  yielded  results 
that did not differ in the NFMBam-  versus the wild-type 
mice, and we ascribe this to the fact that the 20% decrease 
in the levels of the mNFH p3+ isoforms observed by West- 
ern blot methods  in these  transgenic  mice was not large 
enough  to  be  visualized  by immunohistochemistry.  Not- 
withstanding,  the immunohistochemical studies  described 
here served to confirm and extend the key immunochemi- 
cal  data.  Less  detailed  studies  of the  3-mo-old  NFM37 
mice  yielded  similar  observations  (data  not  shown).  Fi- 
nally, although perikaryal and/or axonal aggregates of NFs 
have  been detected  in other lines  of NF transgenic  mice 
(C6t6 et al., 1993; Xu et al., 1993; Eyer and Peterson, 1994; 
Vickers et al., 1994), none were observed in the transgenic 
mice  studied  here  or  in  the  1-yr-old  NFMBam-  mice 
(data not shown). These data suggest that the overexpres- 
sion of NFM protein in these two lines of transgenic mice 
is not incompatible with the efficient export of NFs from 
perikarya into axons and the subsequent orthograde trans- 
port of NFs down the axon. 
Packing Density of  Neurofilaments Is 
Increased in Axons of Transgenic Mice versus Those 
of Wild- Type Mice 
Electron microscopic studies were performed to compare 
the packing density of NFs in telencephalic white-matter 
axons of the transgenic mice versus those of the wild-type 
mice. To do this, we focused our quantitative studies of ax- 
onal NFs on the alveus because this is a reproducibly iden- 
tifiable white-matter tract of the hippocampus wherein we 
noted large differences in the intensity of the NF protein 
immunoreactivity between  the NFMBam-  and the wild- 
type mice. The axons in this area are in the 0.1-1.5 tzm in 
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RNAs  in  transgenic  lines.  RNase protection assays  were per- 
formed as described  in  experimental procedures.  In A, 20,000 
cpm of an mNFL-specific  probe and  10,000 cpm of a  murine 
I~-actin probe were hybridized  with yeast tRNA (lane  1), total 
brain RNA from a transgenic NFM37 mouse (lane 2), a wild-type 
NFM37 littermate (lane 3), a transgenic NFMBam- mouse (lane 
4), or a wild-type  NFMBam-  mouse (lane  5).  Protected frag- 
ments were separated as double-stranded RNA on a 6% native 
polyacrylamide  gel. Positions  of the actin  and mNFL protected 
fragments are  indicated.  In B,  hybridizations  were performed 
with 40,000 cpm of an mNFM-specific probe and 10,000 cpm of a 
murine GAPDH probe. Lane order is the same as in (A). Expo- 
sures in both A and B were for 18 h. 
diameter range, with most in the 0.3-0.8 Ixm size class. For 
quantitative  study,  alvear axons were  arbitrarily divided 
into six size categories, with axonal diameters of 0.1-0.3, 
0.3-0.5,  0.5-7,  0.7-0.9,  0.9-1.2,  and  1.2-1.5  t~m.  Fig.  9 
shows the representative axons (A) and their NF density 
distribution histogram (B) from the second size category. 
These data reveal a  shift to the  right in the NF packing 
density for the NFMBam-  mice. The number of NFs in 
180  axons of this  category from three  NFMBam-  mice 
and 180 axons of the same size class from three wild-type 
mice were counted, and the results are shown in Table III. 
The total NF number of the NFMBam-  mice was 8,100 
and  that  of the  wild-type  mice  was  5,580.  The  average 
number of NFs per axon was 45 in the NFMBam-  mice 
and 31  per axon in the wild-type mice (P <  0.01).  Thus, 
the  axons had  a  higher NF packing density in the  trans- 
genic versus the wild-type mice; the same trend  was also 
demonstrated in all other axonal categories (Table III). 
Discussion 
The studies described here sought to gain insights into the 
Table II. RNase Protection Assays of NFM37 and 
NFMBam- versus Control 
NFL  NFM 
NFM37  112.7 -  9.7  107.3 -+ 9.2 
NFM37  control  100.2 ~- 3.1  100.2 --- 12.2 
NFMBam-  109.8 --- 11.5  99.1  --- 11.0 
NFMBam-  control  100.0 ___ 3.4  101.2 _+ 8.5 
Quantitation of mouse NFL and NFM mRNA in transgenic lines. RNase pro- 
tections assays were performed as described in experimental procedures and il- 
lustrated in Fig. 7. Two transgenic and two control adult animals (aged 1-3 too) 
were analyzed from each line. Expression in control animals was set at 100 and 
values are given with standard deviations. Results are the average of at least six 
observations on whole-brain RNA in each animal. Values for paired t tests are: 
NFL in NFM37 vs. control, P  =  0.048, and NFMBam-  vs. control, P  =  0.059; 
NFM in NFM37 vs. control, P  = 0.013, and NFMBam-  vs. control, P  =  0.678. 
regulation of NF protein metabolism and the stoichiome- 
try of NF subunits using transgenic technology. We have 
shown  that  overexpressing  hNFM  in  the  CNS  of  both 
types of transgenic mice induces increased levels of mNFL 
proteins  in  addition  to  reducing  levels  of  highly  phos- 
phorylated isoforms of mNFH and increasing the packing 
density of NFs in large-diameter CNS axons. We speculate 
that  these  effects are  specific to  NFM because previous 
studies of transgenic mice that express NFL or NFH did 
not  evidence  similar  changes.  The  observations  on  the 
spacing of NFs in CNS axons suggest that neurons try to 
accommodate increased  NFs  in  their  axons  by reducing 
their  interfilamentous  spaces.  The  concomitant  decrease 
in mNFH p3+ isoform is compatible with the view that the 
decrease of phosphorylation state of the carboxy terminal 
MPR domain of NFH increases the packing density of ax- 
onal NFs by reducing the negative charges on NFH side- 
arms, which limits lateral extension of the tail domain of 
NFH away from individual  NFs  (Carden et al.,  1987;  de 
Waegh et al.,  1992;  Cole et al.,  1994;  Nixon et al.,  1994). 
Taken  together,  the  data  from these  two  lines  of trans- 
genic  mice  have  two  important  implications  for  under- 
standing how the NF network is regulated in neurons, that 
is, these data suggest that (1) NFM may play a  dominant 
role in the in vivo regulation of NFL levels, the stoichiom- 
etry of NF subunits and the phosphorylation state of NFH, 
and (2) the packing density of NFs in CNS axons is deter- 
mined by both the NF numbers and the phosphorylation 
state of NFH. 
Native NFs have been estimated to assemble at molar 
ratios for NFH, NFM, and NFL, ranging from 1:2:2 to 1:2:9 
depending on the species and neuronal populations inves- 
tigated  (Mori  and  Kurokawa,  1980;  Shecket  and  Lasek, 
1980;  Brown  et  al.,  1981;  Moon  et  al.,  1981;  Chiu  and 
Norton,  1982;  Scott  et  al.,  1985).  Although  all three  NF 
subunit proteins are competent to self-assemble into long 
IFs when combined together in vitro (Balin and Lee, 1991; 
Liem and Hutchison, 1982), NFL forms a filamentous net- 
work of IFs in vivo only in the presence of either NFM or 
NFH (Ching and Liem, 1993; Lee et al., 1993). Further, an 
imbalance in the molar ratio of NF proteins has been im- 
plicated as a mechanism responsible for certain neurode- 
generative conditions such as motor neuron diseases (C6t6 
et al., 1993; Xu et al., 1993).  This is consistent with the no- 
tion that changes in the molar ratio of NF proteins may al- 
ter the transport of NFs down axons, thereby resulting in 
the  accumulation of perikaryal and  axonal aggregates of 
NFs. Thus, disruption of mechanisms that regulate the stoi- 
chiometry of the subunit proteins of NFs may impair the 
function of neurons and lead to lethal consequences. 
It is possible that one or more of the NF triplet proteins 
serve to regulate and maintain the stoichiometry of these 
subunits in intact NFs. Since transgenic mice that overex- 
press different NF subunits seem to tolerate a wider range 
in the levels of NFL compared to NFH and NFM (Mon- 
teiro et al., 1990; Cote et al., 1993; Xu et al., 1993; Vickers 
et al., 1994), NFL probably is unlikely to regulate the sto- 
ichiometry of NF proteins.  Further,  the  delayed appear- 
ance of NFH during development suggests that NFH also 
is  unlikely  to  regulate  NF  stoichiometry.  However,  the 
present studies show that an exogenous hNFM protein be- 
comes incorporated into the cytoskeleton in vivo and reg- 
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teins. 
The ratio of hNFM to mNFM proteins was high in the 
neocortex and the hippocampus in NFMBam-  mice, but 
low in the brain stem and the  spinal cord. However, the 
absolute amounts of transgenic hNFM proteins in the lat- 
ter two regions were equal to or greater than those in the 
former two regions, which suggests that the transgene was 
expressed as efficiently in the spinal cord and brainstem as 
in the neocortex and hippocampus. The detection of rela- 
tively low levels of transgenic hNFM in the spinal cord and 
brain stem may in part reflect the fact that many more en- 
Figure  8.  Comparison  of  immunohis- 
tochemical preparations of cortex and the 
alveus  of the  hippocampus probed with 
three  different  anti-NF  antibodies.  A-C 
are NFMBam- mice, and D-F are wild- 
type mice. RMO254 (which recognizes the 
MPR of human NFM protein that is ab- 
sent in the hNFMBam- protein) was used 
as a control antibody to show the similar 
staining  intensity  between transgenic  and 
wild-type  mice  (A  and  D,  respectively). 
The mAb RMO44 (which recognizes  rod 
domains of both hNFMBam- and mNFM 
proteins)  stains  transgenic  tissue  more 
strongly  than the wild-type tissue  (B and 
E, respectively).  The induction  of mNFL 
protein in the transgenic NFMBam- mice 
is evidenced by the stronger staining than 
in the wild-type mice using the rabbit anti- 
NFL antibody (C and F, respectively). 
dogenous  NF  proteins  are  present  in  these  two regions. 
Quantitative  Western  and  Northern  blot data  correlated 
the expression of hNFM protein with the level of hNFM 
mRNA, which suggested that the expression of the trans- 
gene is basically controlled at the transcriptional level and 
that it is subjected to the same transcriptional regulation in 
all of the CNS regions. The NFM27 mice not examined in 
this study expressed relatively low levels of hNFM mRNA, 
resulting in low expression of hNFM and no evidence of 
increased levels of NFL induction by Western blot analysis 
(Lee et  al.,  1992).  Although  the  NFM37  mice expressed 
higher levels of hNFM  proteins in  all four  CNS  regions 
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Hippocampus 
Axon category  Control (n =  180)  NFMBam- (n =  180)  t Test 
0.1--0.3 I~m  15 -  5  30 +_ 14  P  =  0.0015 
0.3-0.5  ~m  29 +- 10  45 +-- 15  P  <  0.001 
0.5-0.7  ixm  56 +-- 16  86 -+ 28  P  <  0.001 
0.7-0.9  ixm  79 -+ 16  119 +_ 38  P  =  0.0013 
0.9-1.2 p~m  110 --- 20  161  -+ 24  P  =  0.0031 
1.2-1.5  izm  151  -  36  196 -+ 24  P  =  0.036 
Number of  NF  per 0.3-0.5  ~u~  Axon 
Figure 9.  Electron microscopic  analyses of the white-matter ax- 
ons in the alveus of the hippocampus in the NFMBam- trans- 
genic mice show  more NFs  and a higher  packing density  than 
similar-sized  axons in the wild-type mice. A shows electron mi- 
crographs of representative alveal axons of the NFMBam- and 
wild-type mice. Magnification:  x60,000. B shows a histogram of 
the numbers of NFs per 0.3-0.5 izm axon in the alveus of the hip- 
pocampus in  the NFMBam-  and wild-type  mice.  The shaded 
bars represent wild-type mice; the horizontal bars, NFMBam- 
mice. The distribution  pattern of the numbers of NF per 0.3-0.5 
~m axons is broader and shifts to the right in the NFMBam- 
mice when compared with wild-type mice. 
examined here, the reasons for this are not obvious. How- 
ever, it is possible that  the  site of integration of the  ge- 
nomic DNA for hNFM in the NFM37 mice influences the 
level of expression of this protein in the CNS. 
Interestingly,  we  noted  a  concomitant  increase  in  the 
levels of mNFL proteins wherever the ratio of hNFM to 
mNFM was high in both of the transgenic lines. These data 
suggest that the relative levels of hNFM, rather than the 
absolute amounts of hNFM,  are responsible for inducing 
the increased expression of mNFL. A similar phenomenon 
had been observed previously for other IFs in the cultured 
ceils. For example, the expression of a keratin type II (i.e., 
K6b) protein was shown to induce the synthesis of a kera- 
tin type I protein in 3T3 fibroblasts transfected with a con- 
struct  encoding  the  K6  IF  protein  (Giudice  and  Fuchs, 
1987).  Similarly,  when  desmin  was  transfected  into  T24 
ceils, it also induced the synthesis of endogenous vimentin 
in these cells (Pieper et al., 1992). The present study is the 
first to  show  an increase in  one subunit  (i.e., NFL) of a 
heteropolymeric IF by another  subunit  (i.e., NFM)  that 
normally is found in the same IF in vivo. Because this was 
seen in two lines of hNFM transgenic mice and correlated 
well with the expression levels of hNFM protein, it is un- 
likely these findings reflect effects due to the site of inte- 
gration  of the  transgene.  Indeed,  the  increase  in  mNFL 
was unique  in  that  there  was no change in the  levels of 
mNFM and mNFH proteins; it also  appeared to be due 
specifically to the overexpression of NFM, because trans- 
genic mice that overexpressed NFL or NFH did not induce 
changes in the levels of the other NF subunits (C6t6 et al., 
1993; Xu et al., 1993; Tu and Lee, unpublished). Thus, we 
infer that a unique function of NFM protein may be to reg- 
ulate  and  maintain  the  stoichiometry of NF  subunits  in 
vivo. This view is also supported by several other lines of 
evidence. First, in lower animal species such as Myxicola 
or lamprey, the major NF subunit has characteristics simi- 
lar to mammalian NFM protein (Chin et al., 1989; Pleasure 
et al., 1989), suggesting that NFM protein is the archetype 
NF protein  of the  CNS.  Second,  during  development of 
the CNS, NFM coexpresses with NFL (Carden et al., 1987; 
Tohyama et al.,  1991)  or appears somewhat earlier than 
NFL  (Tapscott  et  al.,  1981;  Bennett  and  Dilullo,  1985; 
Szaro et al., 1989; Yachnis et al., 1993). Thus, this temporal 
relationship places NFM in a  critical position to regulate 
the synthesis of the other two NF subunits. 
Multileveled  regulatory  mechanisms  have  been  pro- 
posed to control the synthesis of the NFL subunit (Linden- 
baum et  al.,  1988;  Ikenaka et  al.,  1990;  Monteiro  et  al., 
1990;  Nakahira  et  al.,  1990;  Beaudet  et  al.,  1993a,b; 
Shneidman et al., 1993). Our RNase protection assays re- 
vealed no significant increase in mNFL mRNA in either of 
these two lines of transgenic mice, suggesting that the in- 
creased levels of mNFL protein are due to posttranscrip- 
tional  regulatory  mechanisms.  Although  the  nature  of 
these mechanisms is unclear at this time, there are several 
plausible  considerations.  For  example,  since  NFM  pro- 
teins bind with high affinity to single-stranded RNA and 
DNA in vitro (Traub et al., 1985), it is possible that such 
interactions are involved in regulating NF protein levels in 
vivo. Alternatively, the  assembly of IF proteins into fila- 
ments may increase the  levels of an IF subunit in trans- 
fected cells by retarding the degradation of the artificially 
expressed protein  (Giudice and Fuchs,  1987;  Knapp and 
Franke, 1989;  Kulesh et al., 1989).  Thus, the overexpres- 
sion of NFM protein could increase the levels of mNFL 
protein  by copolymerizing with  and  stabilizing  all  avail- 
able mNFL. In this regard, it is interesting that the expres- 
sion of K14 cytokeratin without its partner K6b in trans- 
fected 3T3 fibroblasts led to the formation of aggregates of 
K14, while no aggregates formed when both K14 and K6b 
were coexpressed in transfected cells, where they formed a 
network (Giudice and Fuchs, 1987).  This finding may ex- 
The Journal of Cell Biology, Volume 129, 1995  1638 plain why no NF inclusions are found in the NFMBam- 
mice for up to I yr (data not shown). 
Notably, mNFH protein was less extensively phosphory- 
lated in both lines of transgenic mice described here. Al- 
though the decrease in the highly phosphorylated NFHP  3+ 
isoform in the NFMBam- mice might be intepreted to re- 
flect a decrease in total mNFH protein, the appearance of 
a poorly phosphorylated mNFHP- isoform in the NFM37 
mice clearly demonstrates that the extent of phosphoryla- 
tion of mNFH indeed decreases in these transgenic mice. 
Furthermore, the larger decrease in the phosphorylation 
state  of mNFH in the NFM37  mice, compared with the 
NFMBam- mice may be ascribed to the presence of MPR 
in the hNFM, which is fully phosphorylated in the NFM37 
mice.  Thus,  we  infer  that  the  phosphorylation state  of 
mNFH protein is regulated by the amount and phosphory- 
lation state of hNFM proteins. 
Electron microscopy showed that the axons of NFMBam- 
mice had more NFs packed at a higher density than con- 
trol mice. Because the packing density of myelinated ax- 
ons is  determined by both the  number  of NFs  and  the 
phosphorylation state of these NFs (Monteiro et al., 1990; 
de Waegh  et al.,  1992;  Gotow et al.,  1994; Nixon et al., 
1994), our data suggest that hippocampal neurons of the 
NFMBam- mice compensate for the increased number of 
NFs by reducing the extent to which the mNFH is phos- 
phorylated. This in turn allows NFs to pack at higher den- 
sities without increasing the caliber of axons. The more 
obvious  reduction  of  mNFH  phosphorylation  state  in 
NFM37 mice compared with the NFMBam- mice further 
substantiates the view that both NFM and NFH proteins 
contribute to regulating the NF packing density and that 
their phosphorylation state  is  regulated  in  a  coordinate 
manner. With more potential phosphorylation sites in its 
tail domain,  the NFH protein may be a  better interfila- 
mentous  spacer than  NFM.  The neocortical and  hippo- 
campal neurons in transgenic mice may prefer NFM as the 
spacer rather than NFH because their myelinated axons 
are small.  That the extent of phosphorylation of mNFH 
protein  in  spinal  cord remains  unchanged  in  transgenic 
mice may reflect the different capacities of the myelinated 
axons in brain  or spinal  cord to accommodate NF side- 
arms. Accordingly, the myelinated axons in the spinal cord 
are much larger in diameter than those in the brain. The 
random distribution pattern of interneurofilamentous spaces 
(Price et al., 1988) suggests that the myelinated axons in 
the  spinal  cord could accommodate variable number  of 
NFs. Thus, the increase in NFM and NFL proteins may 
have less of an impact on spinal cord versus brain axons. 
Accordingly, this increase does not change the extent of 
phosphorylation of mNFH in the spinal cord. This inter- 
pretation is supported by the electron microscopy studies 
of the sciatic nerves of NFM37 and control mice, which did 
not reveal any significant change in the packing density of 
NFs or the diameter of these  axons in the NFM37 mice 
(data not shown). 
While  these  and  several  of the  other issues  discussed 
earlier concerning the mechanisms that regulate the me- 
tabolism and function of NFs remain to be specified in de- 
tail, the studies of transgenic mice described here suggest 
that NFM might play a dominant role in the in vivo regula- 
tion of NFL expression, the stoichiometry of NF subunits, 
and the phosphorylation state of NFH in the brain. Fur- 
ther, our studies imply that the phosphorylation state of 
both NFM and NFH proteins plays a role in regulating the 
packing density of NFs in CNS axons. Additional insights 
into  the  validity of these  inferences should  help  clarify 
how alterations in the metabolism of NF proteins contrib- 
ute to the pathogenesis of human neurodegenerative dis- 
eases characterized by a disruption of the neuronal cyto- 
skeleton. 
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